Individuals Discontinuing Slimming Injections Gain Back Pounds Four Times Faster Compared to People Using Diet and Exercise

Fresh analysis reveals that people who discontinue blockbuster slimming jabs like Mounjaro or Wegovy can put back on shed pounds far faster than those who stop traditional diet and exercise programs.

Research printed in a prominent medical journal points out that while obese people frequently drop substantial amounts of their body weight while on the medication, the weight returns at an estimated rate of 0.8 kg per month once they quit.

"People using these drugs need to be aware of the risk of quick rebound weight gain when the medication ends," cautioned researcher Dr. Susan Jebb.

Such speed of recovery implies a return to original weight within about a year and a half.

Analyzing Therapies

The research, which reviewed 37 of trials involving over 9,000 of patients, compared the effects of the injectable medications with older methods.

Researchers note that people who shed pounds through lifestyle changes alone generally experience a slower creep back—approximately 100 grams monthly—after stopping.

Explaining the Quick Rebound

Experts suggest the mechanism of the jabs explains the accelerated regain.

GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which moderates hunger.

"Sustained high doses of GLP-1 concentrations several times higher than normal might result in the body to generate a reduced amount of its own natural hormone, and could reduce sensitivity to its actions," noted Dr. Adam Collins, a dietetics expert.

"Stopping of this hormone supplement means hunger is no longer kept in check, making overeating much more probable."

A Chronic Issue?

Medical guidelines suggest the jabs for people with weight-linked health risks, accompanied by prescribed lifestyle changes.

Professionals say that, considering the significant potential of weight regain, the treatment might need to be ongoing.

This opinion is supported by drug manufacturers, who note that the results "highlight the long-term character of excess weight," akin to managing conditions like high blood pressure.

Patient Experiences

People who have come off the medication explain a intense return of hunger.

"It felt as if something flipping and you become extremely hungry," said a patient.

This difficulty is exacerbated if patients have not established lasting lifestyle or habit modifications during therapy.

Growing Use

Recent estimates suggest that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with desire being substantial.

• Adoption is more common among women than men.
• The 40s and 50s demographic shows the highest level of interest.
• A large proportion access the medications through private healthcare rather than public health services.

Finally, experts stress that while the jabs are potent tools for weight loss, they are not a standalone fix and maintained weight loss likely depends on combined behavioural changes.